Patterns of finasteride and dutasteride use in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial cohort: effects of socio-demographic factors and a black box warning
Background: Five-alpha reductase inhibitors (5-ARIs), specifically finasteride and dutasteride, have been shown to significantly reduce prostate cancer incidence. However, these agents were also associated with a significant increase in the detection of high-grade prostate cancer leading to an FD...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MRE Press
2022-01-01
|
Series: | Journal of Men's Health |
Subjects: | |
Online Access: | https://article.imrpress.com/journal/JOMH/18/1/10.31083/j.jomh1801019/1875-6859-18-1-019.pdf |